• Explore /
  • Poster
  • / Updated results of European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 1202 cabazitaxel in patients with metastatic or inoperable locally advanced dedifferentiated liposarcoma.

Updated results of European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 1202 cabazitaxel in patients with metastatic or inoperable locally advanced dedifferentiated liposarcoma.

Abstract Poster

Authors

null

Roberta Sanfilippo

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Roberta Sanfilippo , Richard L Hayward , Jammbe Musoro , Charlotte Benson , Michael Gordon Leahy , Antonella Brunello , Jean-Yves Blay , Neeltje Steeghs , Ingrid Desar , Nasim Ali , Alice Hervieu , Khin Thway , Sandrine Marreaud , Saskia Litiere , Bernd Kasper

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Bone Tumors

Clinical Trial Registration Number

NCT01913652

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 11518)

DOI

10.1200/JCO.2021.39.15_suppl.11518

Abstract #

11518

Abstract Disclosures

Similar Posters

First Author: Roberta Sanfilippo

First Author: Makoto Endo

First Author: Mark Andrew Dickson

First Author: Gregory Michael Cote